Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
Acta Endocrinol (Buchar) ; 16(2): 208-215, 2020.
Article in English | MEDLINE | ID: mdl-33029238

ABSTRACT

CONTEXT: Incidentally discovered solid adrenal tumors must be evaluated from two points of view: the risk of malignancy and the secretory feature. OBJECTIVE: Our aim was to evaluate the surgical technique option in relation with clinical and histopathologic features. DESIGN: We performed a retrospective study that included patients with adrenal gland tumors. SUBJECTS AND METHODS: All patients were operated between 2012 and 2019 by the same surgical team in a single center. RESULTS: The batch included 102 patients with adrenal tumors operated through open surgery (OS, n=41) and laparoscopic surgery (LS, n=61). Tumor localization was especially on the right adrenal gland (n=52, 50.98%). Primary origin of the adrenal gland tumors was in 82 cases (80.39%) and a metastatic origin in 16 cases. Average dimension for surgical resected tumors was 4.02 cm (0.9-12 cm) for the LS group as compared to 7.22 cm (1.3-19 cm) for OS group with a predominant type of surgery represented by adrenalectomy and a conversion rate of 2.94%. The hospital stay was 7.22 days (5-12 days) in the LS group versus 12.72 days (6-57 days) in OS group with significant differences (p<0.01). Also, the postoperative recovery was significantly different (6.5 days versus 2.62 days, p<0.01). CONCLUSION: Laparoscopic approach represents the gold standard in adrenal gland tumors less than five centimeters in size. Adrenalectomy is mostly performed by LS and adenoma is the most frequent histopathologic type, while pheochromocytoma is operated through OS. LS has a significantly reduced hospitalization and postoperative stay compared to OS.

2.
Rev Med Chir Soc Med Nat Iasi ; 120(2): 316-20, 2016.
Article in English | MEDLINE | ID: mdl-27483711

ABSTRACT

AIM: To assess bilateral breast cancer patients, initially diagnosed with stage II unilateral breast cancer. MATERIAL AND METHODS: 113 patients with stage 0-II breast cancer diagnosed between 1983 and 2011 were assessed. Of these, 8 patients had bilateral breast cancer: 7 patients with metachronous bilateral breast cancer and 1 patient with synchronous breast cancer. Breast ultrasound, mammography, computed tomography and magnetic resonance imaging were used to diagnose recurrence, loco regional and distant metastasis. RESULTS: Age at diagnosis ranged from 37 to 59 years, with a maximum age incidence in the 4th decade (age between: 31-40 years). The average time interval between the two breast cancers was 8.125 years. The most common histological type was invasive ductal carcinoma. All eight patients with bilateral breast cancer had at least one type of recurrence/metastasis, mostly in the liver, and statistically the pleuropulmonary and liver metastases were the most frequent causes of death. CONCLUSIONS: Patients in the 4th decade diagnosed with unilateral breast cancer are at risk of developing bilateral breast cancer. In metachronous breast cancer, the time interval between the detection of the second breast cancer and death is directly proportional to the time interval between the two breast cancers. TASTASES, DEATH.


Subject(s)
Breast Neoplasms/diagnosis , Carcinoma, Ductal, Breast/diagnosis , Neoplasm Recurrence, Local/diagnosis , Neoplasms, Multiple Primary/diagnosis , Neoplasms, Second Primary/diagnosis , Adult , Breast Neoplasms/mortality , Breast Neoplasms/surgery , Carcinoma, Ductal, Breast/mortality , Carcinoma, Ductal, Breast/surgery , Early Detection of Cancer , Female , Humans , Middle Aged , Neoplasm Invasiveness , Neoplasm Recurrence, Local/mortality , Neoplasm Recurrence, Local/surgery , Neoplasm Staging , Neoplasms, Multiple Primary/mortality , Neoplasms, Multiple Primary/surgery , Neoplasms, Second Primary/mortality , Neoplasms, Second Primary/surgery , Prognosis , Retrospective Studies , Treatment Outcome
3.
Rev Med Chir Soc Med Nat Iasi ; 120(3): 631-4, 2016.
Article in English | MEDLINE | ID: mdl-30142263

ABSTRACT

The particularity of the presented case is bilateral synchronous male breast cancer of uncommon histologic type ­ invasive cribriform carcinoma. In the practice of our surgical unit it is the first and only case of synchronous bilateral male breast cancer. The patient was followed up regularly for the last 4 years after a modified radical bilateral mastectomy with axillary lymph node clearance followed by adjuvant chemotherapy and endocrine therapy and he showed no signs of local recurrence or metastatic disease.


Subject(s)
Breast Neoplasms, Male/pathology , Carcinoma, Ductal, Breast/pathology , Neoplasms, Multiple Primary/pathology , Axilla , Breast Neoplasms, Male/diagnostic imaging , Carcinoma, Ductal, Breast/diagnostic imaging , Chemotherapy, Adjuvant , Humans , Lymph Node Excision , Male , Mastectomy , Mastectomy, Modified Radical , Middle Aged , Neoplasms, Multiple Primary/diagnostic imaging
4.
Rev Med Chir Soc Med Nat Iasi ; 119(2): 374-8, 2015.
Article in English | MEDLINE | ID: mdl-26204639

ABSTRACT

AIM: To analyze the main causes of death in patients with stage 0-II breast cancer who undergo breast conserving surgery or radical mastectomy, and to establish the role of imaging surveillance protocols following breast cancer treatment. MATERIAL AND METHODS: We conducted a retrospective medical record review between January 2005 and December 2012, when breast cancer was the primary cause of death for 113 inpatients. All patients were admitted to the Oncology Clinic of the Iasi Regional Cancer Institute (IRCI), Romania. Patients were stratified by clinical stage 0, I and II, of which 33 (29.2%) patients were managed by breast conservation therapy and 80 (70.8%) underwent radical mastectomy. From the patient medical records all diagnostic imaging studies performed (ultrasound, radiography and computed tomography) were identified and analyzed according to a standard protocol for imaging the postoperative breast. RESULTS: Bone, liver, lung, lymph nodes and local-regional recurrence were the most common sites for metastasis, while the most frequent cause of death were metastases to the liver, pleura, lung and brain. The time interval between recurrence and death ranged from 0-24 years among patients with one type of metastasis, and decreased to 0-3 years since the last recurrence for patients with multiple metastases. CONCLUSIONS: The current imaging protocol for monitoring the postoperative breast could be optimized to improve the prognosis and quality of life in patients with stage 0-II breast cancer.


Subject(s)
Breast Neoplasms/pathology , Breast Neoplasms/surgery , Inpatients , Mastectomy, Radical , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/surgery , Adult , Breast Neoplasms/mortality , Breast Neoplasms/therapy , Female , Follow-Up Studies , Humans , Inpatients/statistics & numerical data , Mastectomy/methods , Mastectomy, Radical/statistics & numerical data , Mastectomy, Segmental/statistics & numerical data , Neoplasm Invasiveness , Neoplasm Recurrence, Local/mortality , Neoplasm Recurrence, Local/therapy , Neoplasm Staging , Prognosis , Quality of Life , Retrospective Studies , Risk Assessment , Risk Factors , Romania/epidemiology , Survival Rate
5.
Chirurgia (Bucur) ; 110(1): 38-42, 2015.
Article in English | MEDLINE | ID: mdl-25800314

ABSTRACT

The treatment of breast cancer has evolved over the past 40 years. Followed by radiotherapy, conservative surgical procedures are options increasingly more preferred by surgeons and patients. This paper aims to highlight comparative aspects of local and distant recurrence in patients who had radical or conservative surgery for breast cancer. We performed a retrospective study between January, 2005 - July 2013, that included 477 breast cancer patients from the Regional Institute of Oncology Iasi, who were evaluated by imaging in the Radiology Clinic,Hospital "St. Spiridon", Iasi. We included in the study patients in curable stages 0, I and II; 248 (52 %) patients had radical surgery and 229 (48 %) patients had conservative surgery. We used the ultrasound scan, mammography, CT and MRI, that allowed diagnosis, pretherapeutic staging and diagnosing of the loco-regional and distant recurrences. Local and distant recurrences were higher in patients with conservative surgery(86 recurrences), than in patients who had radical surgery (55 recurrences). Local recurrences are more common in younger individuals and in patients treated with conservative surgery and radiotherapy, than in patients with radical mastectomy.The most common metastases are located in the bone, liver and lung.


Subject(s)
Breast Neoplasms/diagnosis , Breast Neoplasms/epidemiology , Mastectomy, Modified Radical , Mastectomy, Segmental , Neoplasm Recurrence, Local/diagnosis , Neoplasm Recurrence, Local/epidemiology , Adult , Aged , Aged, 80 and over , Breast Neoplasms/radiotherapy , Breast Neoplasms/surgery , Breast Neoplasms/therapy , Female , Humans , Incidence , Middle Aged , Neoplasm Staging , Radiotherapy, Adjuvant , Retrospective Studies , Risk Assessment , Risk Factors , Survival Analysis , Treatment Outcome
6.
Chirurgia (Bucur) ; 109(4): 480-5, 2014.
Article in English | MEDLINE | ID: mdl-25149610

ABSTRACT

OBJECTIVE: Surgery remains the best curative option for oesophageal cancer. This demanding intervention performed on a high risk patient is accompanied by high morbidity and mortality rates. The aim of this study was to analyse the preoperative risk assessment using different comorbidity models inpatients operated for esophageal cancer in a tertiary unit. METHODS: A retrospective study was conducted on aprospectively collected database. The performance of several prognostic scores (POSSUM, P-POSSUM, O-POSSUM, Charlson and age adjusted Charlson, ASA score) was assessed in terms of early postoperative outcomes. RESULTS: Out of 137 patients diagnosed with oesophageal cancer, esophagectomy was performed in 43 cases.Postoperative mortality (11.62%) was best predicted by POSSUM score (10.48; 95% CI 9.37 -11.66). The observed morbidity was 58.13%, higher than that expected by POSSUM (48.24%; 95%CI, 44.82-51.66) with a morbidity ratio O E of 1.2. The area under the ROC curve for the physiological score of POSSUM and age adjusted Charlson index showed a good discriminatory power. The best performance was obtained for POSSUM equation, who showed to have the highest area under the ROC curve (0.826; 95%CI, 0.67-0.92). CONCLUSIONS: A thoroughly assessment of comorbidities and the surgeon's clinical assessment remain the best tool for patient selection for surgery.


Subject(s)
Esophageal Neoplasms/surgery , Esophagectomy , Postoperative Care , Esophageal Neoplasms/diagnosis , Esophageal Neoplasms/mortality , Esophagectomy/methods , Esophagectomy/mortality , Female , Hospitals, University , Humans , Male , Middle Aged , Preoperative Care , Prognosis , ROC Curve , Retrospective Studies , Risk Assessment , Risk Factors , Severity of Illness Index , Survival Analysis , Time Factors , Treatment Outcome
7.
Rev Med Chir Soc Med Nat Iasi ; 118(4): 1062-7, 2014.
Article in English | MEDLINE | ID: mdl-25581970

ABSTRACT

AIM: Multifactorial analysis of local and lymph node recurrences in stage 0-II breast cancer treated by conservative or radical surgery. MATERIAL AND METHODS: In the interval January 1, 2005-July 31, 2013, 477 breast cancer patients were assessed by imaging techniques at the Radiology Clinic of Iasi "Sf. Spiridon" Hospital and Radiology Service of the Iasi Regional Cancer Institute. Of these 229 (48%) patients underwent conservative surgery and 248 (52%) patients radical surgery. RESULTS: Local recurrences were 2.8 times more frequent in conservatively vs. radically treated patients, and lymph node recurrences 2 times more frequent in patients treated conservatively. Breast tumors larger than 3 cm in diameter were at higher risk for local and distant recurrence in lymph nodes. CONCLUSIONS: Assessment in patients with local and lymph nodes recurrences of the relative risk for developing other types of recurrences (bone, pleuro pulmonary, liver, brain metastases) indicated that these are a risk factor for other types of recurrences, influencing the prognosis of patients. Local recurrences showed a higher relative risk for other types of recurrences than nodal recurrences.


Subject(s)
Breast Neoplasms/pathology , Breast Neoplasms/surgery , Mastectomy , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/surgery , Adult , Aged , Aged, 80 and over , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/therapy , Chemotherapy, Adjuvant , Female , Humans , Lymph Node Excision , Mastectomy/methods , Mastectomy, Segmental/methods , Middle Aged , Neoplasm Recurrence, Local/therapy , Neoplasm Staging , Prognosis , Radiography , Radiotherapy, Adjuvant , Retrospective Studies , Risk Assessment , Risk Factors , Sentinel Lymph Node Biopsy , Treatment Outcome
8.
Rev Med Chir Soc Med Nat Iasi ; 116(1): 150-6, 2012.
Article in Romanian | MEDLINE | ID: mdl-23077888

ABSTRACT

UNLABELLED: Peritoneal carcinomatosis of gastrointestinal origin (PC-GI) is an advanced digestive tumor and is found in 10-30% of patients (P) with primary surgery for cancer (C) and up to 50% of C recurrences. AIM: To evaluate the main characteristics, ethio-pathogenesis, prognosis and imaging to track of P with PC-GI admitted to the Third Surgical Clinic, "St. Spiridon" Hospital, Iasi. MATERIAL AND METHODS: A retrospective study was carried out on series of 203 patients admitted in the period June 2006 - March 2011. The patients were aged between 27-80 years (average 62), with a women/men ratio of 95/108. The duration of hospitalization was between 1 and 61 days, with an average of 13.5 days for emergency cases and 15 days for elective cases. The data from observation files, the operating protocols, pathology reports and follow-up files were collected and analyzed. RESULTS: 136 patients were hospitalized with synchronous PC (the most common gastric N = 60) and 67 with metachronous PC (the most common colon N = 29). Imaging investigations consisted of ultrasound and computer tomography that showed a sensibility and specificity of 80% and 73% respectively, mainly in regard to ascites but less in assessing the presence of peritoneal deposits. The most common complication was septic shock and mortality was 9.5% (17 patients). Average survival was 5.7 months. CONCLUSION: PC-GI is a disease with a poor prognosis, posing difficulties in early diagnosis, establishing the surgical indication and protocol. Consistent advances in systemic and locoregional chemotherapy, surgical techniques, intraoperative radiotherapy, as well as immunotherapy are expected to improve prognosis.


Subject(s)
Carcinoma/surgery , Gastrointestinal Neoplasms/surgery , Neoplasms, Multiple Primary/surgery , Neoplasms, Second Primary/surgery , Peritoneal Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/therapeutic use , Carcinoma/diagnosis , Carcinoma/drug therapy , Carcinoma/mortality , Chemotherapy, Adjuvant/methods , Female , Gastrointestinal Neoplasms/diagnosis , Gastrointestinal Neoplasms/drug therapy , Gastrointestinal Neoplasms/mortality , Humans , Length of Stay , Male , Middle Aged , Neoplasm Seeding , Neoplasms, Multiple Primary/diagnosis , Neoplasms, Multiple Primary/drug therapy , Neoplasms, Multiple Primary/mortality , Neoplasms, Second Primary/diagnosis , Neoplasms, Second Primary/drug therapy , Neoplasms, Second Primary/mortality , Peritoneal Neoplasms/diagnosis , Peritoneal Neoplasms/drug therapy , Peritoneal Neoplasms/mortality , Prognosis , Retrospective Studies , Romania/epidemiology , Survival Rate , Treatment Outcome
9.
Rev Med Chir Soc Med Nat Iasi ; 116(2): 506-14, 2012.
Article in Romanian | MEDLINE | ID: mdl-23077945

ABSTRACT

UNLABELLED: This study provides a clinical and paraclinical algorithm of assessment of gastrointestinal stromal tumors (GIST), with the possibilities and limits of their current management. It is focused on defining an optimal imaging and anatomoclinic diagnosis protocol. In the absence of specific algorithm of surgical management, the study proposes an evaluation of possible histologic diagnosis and the indication for surgery, and the assessing the immediate results of thesurgical treatment. MATERIALS AND METHODS: A retrospective analysis was carried out over a period of 8 years (2004-2011), including patients with pathologic results of resection specimens revealing the stromal nature. There were analyzed the tumor characteri stics, the association with other digestive tumors, the biologic behavior, clinical manifestations and the comorbidities of the patient, the indication for surgery, and also, the surgical morbidity and mortality. From 2004 to 2011 there have been operated 24 cases of GIST diagnosed histologically by common stains. Among them, a total of 16 patients (beginning with 2007) were confirmed immunohistochemicaly. RESULTS: During the study, each clinical suspicion of GIST was an opportunity for thorough assessment of the clinical picture, imaging studies or anatomoclinical aspects (intraoperative macroscopical aspects, pathological and immunhistochemical examination). We have tried a standardization of diagnostic and therapeutic algorithm. Positive diagnosis of GIST was clinicaly suspected in patients with digestive tract tumors (22 cases out of 24) without mucosal involvement, or based on intraoperative macroscopic appearance. The lesions were confirmed by the pathologist. The surgical morbidity (4 cases--16.6%), was to the surgery (a single case of anastomotic leakage) or due to patient's comorbidities (diabetus, chronic renal failure, etc), and has been framed to acceptable extent. No deaths occurred in relation to the surgery. CONCLUSIONS: The diagnostic difficulties are overcome in terms of a positive laboratory features revealed by immunhistochemical examination. The surgical approach of GIST is different from that of a carcinoma. The postoperative immunhistochemical confirmation of GIST, leads the patient to a specific adjuvant treatment.


Subject(s)
Gastrointestinal Neoplasms/surgery , Gastrointestinal Stromal Tumors/surgery , Adult , Aged , Aged, 80 and over , Algorithms , Female , Gastrointestinal Neoplasms/diagnosis , Gastrointestinal Neoplasms/epidemiology , Gastrointestinal Stromal Tumors/diagnosis , Gastrointestinal Stromal Tumors/epidemiology , Humans , Immunohistochemistry , Incidence , Male , Middle Aged , Retrospective Studies , Risk Assessment , Risk Factors , Romania/epidemiology , Time Factors , Treatment Outcome
10.
Rev Med Chir Soc Med Nat Iasi ; 116(4): 1106-11, 2012.
Article in English | MEDLINE | ID: mdl-23700897

ABSTRACT

Colorectal cancer (CRC) is the third form of cancer in both men and women. In Romania, the incidence of CRC in 2000 is 17.74 %ooo, in 2002 becoming the second cause of death. We reviewed a series of studies that are related to colon cancer and studied the epithelial-mesenchymal transition at the front of tumor invasion (EMT). Cellular phenotypic changes characteristic of EMT can be induced by the absence of transition cofactor (p300) involved in cellular regulation. Loss of syndecan-l marker is associated with local tumor stage and metastasis. Modulators of protein kinase resistance was associated with changes in genes involved in EMT (including vimentin hyperexpression) and genes involved in invasion (N-cadherin) with a decrease expression of genes involved in epithelial cell adhesion (E-cadherin). Progression in colon cancer is characterized by activating mutations in Ras genes and tumor growth factor action. Vimentin expression associated with EMT initiates molecular program. One of the characteristics of EMT is the loss of E-cadherin. TGF-p (transforming growth factor beta) induces epithelial-mesenchymal transition in colon cancer cell lines with the microsatellite stability, inducing cell invasion and migration. EMT is a critical early event involved in invasion and metastasis of colorectal cancer, characterized by the presence of markers specific to each phenotype, epithelial or mesenchymal. Multiple biomarkers involved in the induction of EMT may represent future therapeutic target in the treatment of colonic neoplasia.


Subject(s)
Biomarkers, Tumor/blood , Colonic Neoplasms/genetics , Colonic Neoplasms/pathology , Epithelial-Mesenchymal Transition , Mutation , Syndecan-1/blood , Cadherins/blood , Colonic Neoplasms/epidemiology , Colonic Neoplasms/metabolism , Gene Expression Regulation, Neoplastic , Genes, ras/genetics , Humans , Incidence , Neoplasm Invasiveness , Neoplasm Staging , Phenotype , Romania/epidemiology , Transforming Growth Factor beta/blood , Vimentin/blood
11.
Rev Med Chir Soc Med Nat Iasi ; 116(4): 1112-7, 2012.
Article in English | MEDLINE | ID: mdl-23700898

ABSTRACT

UNLABELLED: B-cell-specific Moloney murine leukemia virus integration site 1 (Bmi-l) is a member of polycomb group, which participates in axial patterning, hematopoiesis, cell cycle regulation, and senescence. Overexpression of Bmi-1 has been reported in various human cancers and proved to be associated with poor survival. DISSUCION: Bmi-I is expressed by various tumors and therefore may contribute to malignant transformation. Bmi-I not only can lead mammary epithelial cells to senescence and immortalization, but also plays a key role in breast cancer. A significant correlation was observed between Bmi-1 expression and axillary lymph node metastases in lymph-ductal breast cancer. Bmi-1 is expressed in cervical cancer and correlated with a poorer prognosis, suggesting that this protein participates in the development and progress of cervical cancer. Regarding ovarian cancer, the results of several immunohistochemical studies revealed overexpression of Bmi-1, especially in poorly differentiated ovarian carcinoma. There is a strong correlation between histological grade, clinical stage and its expression. CONCLUSIONS: Human genes of polycomb group correlated with various hematological and epithelial cancers identify new mechanisms of malignant transformation and pave the way for developing new cancer treatments and identify new diagnostic markers. Bmi-1 and its expression in tissues taken from patients with cervical, breast and ovarian cancer could be a marker for diagnosis and prognosis, and not least a potential target of antitumor therapy.


Subject(s)
Biomarkers, Tumor/blood , Breast Neoplasms/metabolism , Ovarian Neoplasms/metabolism , Polycomb Repressive Complex 1/blood , Uterine Cervical Neoplasms/metabolism , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Cell Transformation, Neoplastic , Female , Gene Expression Regulation, Neoplastic , Humans , Lymph Nodes/metabolism , Neoplasm Invasiveness , Neoplasm Staging , Ovarian Neoplasms/genetics , Ovarian Neoplasms/pathology , Predictive Value of Tests , Prognosis , Sensitivity and Specificity , Uterine Cervical Neoplasms/genetics , Uterine Cervical Neoplasms/pathology
12.
Rev Med Chir Soc Med Nat Iasi ; 115(2): 460-5, 2011.
Article in Romanian | MEDLINE | ID: mdl-21870741

ABSTRACT

AIM: this study was aimed at analyzing the immediate postoperative course in rectal cancer patients who underwent a low anterior resection of the rectum with total mesorectal excision. MATERIAL AND METHODS: A retrospective study was carried out on a series of 75 patients operated between January 1, 2004 and December, 31 2010 at the 1lrd Surgical Unit of the Iasi "St. Spiridon" Hospital,. Low anterior resection of the rectum with total mesorectal excision was performed in all the patients. Data from medical files regarding the immediate postoperative course were analyzed. RESULTS: Neoadjuvant therapy was instituted in 32 patients. There were 28 mechanical colorectal anastomoses and 47 manual anastomoses. Protective ileostomy was performed in 46 cases, including I manual anastomosis and 35 mechanical anastomosis cases. Anastomotic fistulas occured in II patients (6 with manual suture and 5 with stapler). Wound complications were identified in 5 cases, while retraction of ileostomy in 2. Two patients died from anastomotic fistula causing abdominal sepsis and multiple organ failure. In both cases ileostomy was performed at the reintervention, concomitantly with drainage of the abdominal abscesses. CONCLUSIONS: Healing of the colorectal anastomosis remains the major problem with low anterior resection of the rectum. Protective ileostomy reduces the risk of serious complications in the event of anastomotic fistula.


Subject(s)
Rectal Neoplasms/surgery , Rectum/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Anastomosis, Surgical/adverse effects , Anastomosis, Surgical/methods , Chemotherapy, Adjuvant , Child , Child, Preschool , Digestive System Surgical Procedures/methods , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Neoadjuvant Therapy , Neoplasm Staging , Radiotherapy, Adjuvant , Rectal Neoplasms/mortality , Rectal Neoplasms/pathology , Retrospective Studies , Surgical Stapling/adverse effects , Surgical Stapling/methods , Survival Analysis , Treatment Outcome
13.
Rev Med Chir Soc Med Nat Iasi ; 113(2): 442-52, 2009.
Article in Romanian | MEDLINE | ID: mdl-21495350

ABSTRACT

Colorectal cancer is the second leading cause of cancer death in the developed world, due to formation of distant metastases. The liver is the primary target organ of metastatic lesions, which substantially influence the morbidity of the disease. At the time of diagnosis of colorectal cancer, about 15% to 20% of patients are found to have synchronous liver metastases and an average of 25% of all patients will develop metachronous liver metastases in the course of their disease. Prompt diagnosis of colorectal liver metastases leads to early treatment, which favours a better prognosis. Consequently, the diagnostic process has shifted from traditional clinical procedures to technologically advanced imaging modalities, such as CT, MRI, FDG-PET and PET-CT. The only curative therapy of colorectal liver metastases is surgical resection using the new methods of tissue excision and haemostasis. Depending on the number of metastases, the location, the volume, the extrahepatic spread and the overall condition of the patient, complete resection is only possible in 20% of all cases. If resection is not feasible, a large number of systemic or local palliative treatment options are available.


Subject(s)
Colorectal Neoplasms/pathology , Colorectal Neoplasms/surgery , Hepatectomy , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Algorithms , Antineoplastic Agents/therapeutic use , Chemotherapy, Adjuvant , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/drug therapy , Hepatectomy/methods , Humans , Liver Neoplasms/diagnosis , Liver Neoplasms/drug therapy , Prognosis , Survival Analysis , Treatment Outcome
14.
Rev Med Chir Soc Med Nat Iasi ; 112(1): 191-5, 2008.
Article in Romanian | MEDLINE | ID: mdl-18677925

ABSTRACT

UNLABELLED: Most of extranodal lymphomas are localized in gastrointestinal tract, gastric lymphoma representing more than 50% of them. The role that Helicobacter pylori (H. pylori) plays in pathogenesis of gastric lymphoma has changed the therapeutic approach. AIMS: Description of morphological features and immunohistochemical pattern of gastric lymphomas from patients admitted in University Hospital "Sf. Spiridon" Iasi. MATERIAL AND METHODS: Thirty four gastric lymphomas were investigated using routine histopathological technics and immunohistochemical staining based on a large panel of antibodies: CD3, CD5, CD20, CD79á, CD23, CD30, cyclin-D1, BCL2, BCL6, ALK1, Ki67, CK-cocktail, anti-H. pylori. RESULTS: All gastric lymphomas were localized in the antrum, most of them being solitary and large-sized tumors. Ninety-seven percent were B-cell lymphomas, 41.17% were mucosa-associated lymphatic tissue lymphomas (MALT lymphomas), and the remaining were high grade lymphomas. Only one case was classified as peripheral T-cell lymphoma. Cytokeratin cocktail immunostaining improved the detection of typical lymphoepithelial lesions, which characterized exclusively the MALT lymphomas. The sensibility for H. pylori detection in gastric lymphoma cases was increased by 22% using anti-H. pylori antibodies. CONCLUSIONS: Immunohistochemistry is a diagnostic method for gastric lymphomas, being useful in identification of lymphoepithelial lesions, detection of H. pylori infection, and is mandatory for lymphomas classification according to WHO criteria.


Subject(s)
Biomarkers, Tumor/analysis , Lymphoma/chemistry , Lymphoma/pathology , Stomach Neoplasms/chemistry , Stomach Neoplasms/pathology , Activin Receptors, Type II/analysis , Antibodies, Bacterial/analysis , Antigens, CD/analysis , Biomarkers, Tumor/immunology , Cyclin D , Cyclins/analysis , DNA-Binding Proteins/analysis , Genes, bcl-2/immunology , Helicobacter Infections/complications , Helicobacter pylori/immunology , Humans , Immunohistochemistry , Ki-67 Antigen/analysis , Lymphoma/microbiology , Proto-Oncogene Proteins c-bcl-6 , Retrospective Studies , Stomach Neoplasms/microbiology
15.
Rev Med Chir Soc Med Nat Iasi ; 112(3): 698-702, 2008.
Article in Romanian | MEDLINE | ID: mdl-20201255

ABSTRACT

Castleman's disease is a rare disorder characterized by proliferation of the lymphoid tissue. Castleman's disease affects both males and females, and may occur at any age. Little is known about how often Castleman's disease actually occurs, other than it is rare, or what causes the disease. The most frequent location of the disease is the mediastinum. The location of the disease in the retroperitoneum is rare and it is usually associated with the generalized form of the disease. We report a case of a 34-year old man with isolated retroperitoneum Castleman's disease of the hyaline-vascular type, which presented as a palpable abdominal mass. The final diagnosis was reached after exploratory laparotomy and resection of the tumor.


Subject(s)
Castleman Disease/diagnosis , Castleman Disease/surgery , Rare Diseases , Retroperitoneal Space , Adult , Diagnosis, Differential , Humans , Laparotomy , Male , Treatment Outcome
16.
Rev Med Chir Soc Med Nat Iasi ; 111(2): 402-15, 2007.
Article in Romanian | MEDLINE | ID: mdl-17983176

ABSTRACT

UNLABELLED: Pancreatic cancer has an increase rate in western countries. From the first pancreaticoduodenectomy (PD) performed by Kausch in 1909, the value of the resection in the treatment of pancreatic head cancer was disputed. AIM: To assess the PD with or without pylorus preservation as surgical treatment for pancreatic cancer. METHODS: Retrospective review of the clinical records of patients undergoing PD for pancreatic cancer. RESULTS: From January 1995 till December 2005, in the First and Third Surgical Units, "St. Spiridon" University Hospital Iasi, Romania, were performed 137 PD. From these, 54 cases were histologic diagnosed with pancreatic cancer; 23 cases underwent pylorus preserving pancreatico-duodenectomy (PPPD) and 31 patients, classical Whipple procedure (PDW). Mean age was 59.07 +/- 1.42 years old (26-75 years old), and male to female ratio was 29 to 25. Jaundice was presented in 51 cases (94.4%), abdominal pain at 39 patients (72.2%) and Curvoisier-Terrier sign at 37 cases (68.7%). Fever was observe only in 4 cases (7.4%). Other biological and imaging parameters (e.g. main diameter of the biliary duct, tumor and wirsung ) were also discussed, but no significant difference was found between PPPD and PDW. Pancreatico-jejunostomy was performed in 41 cases (28 during the PDW and 13 in PPPD) and 13 pancreatico-gastrostomy (3 during PDW and 10 during PPPD). Mean operating time and mean blood loss in the PDW group were 358.22 +/- 10.53 minutes and 587.74 +/- 60.87 mL. After PPPD, these figures were 326.08 +/- 15.04 minutes and 571.74 +/- 90.50 mL, but no significant difference was noted. Delayed Gastric Emptying (DGE) was presented at 15 patients: 8 in PPPD group and 7 in PDW group (p=0.322). Postoperative morbidity rate (excluding DGE) was 33.33% (8 cases in PDW group and 10 in PPPD group). Pancreatic leak has a rate of 5.55% (3 cases--one in PPPD group vs two in PDW group), biliary leak has a rate of 12.96% (4 in PPPD group vs 3 in PDW group)and duodeno-jejunal anastomotic fistula appeared in one cases (PPPD). Acute postoperative pancreatitis is presented in one case (PPPD group) and postoperative hemorrhage appeared in 4 cases (2 in PPPD and 2 after PDW). Hospital stay was 19.91 +/- 2.28 days in PPPD group vs 18.87 +/- 2.24 days in PDW group (p = 0.751). Postoperative mortality rate was 5.5% (one case after PPD and 3 cases after PDW). Histological exam diagnosed ductal pancreatic adenocarcinoma in 51 cases (94.44%). Mean long-term survival rate was 20.98 months (10.52-31.45 months; 95 CI) and no difference was revealed between PPPD and PDW (log rank test - p = 0.796). CONCLUSION: PD should be performed for any pancreatic tumor even without preoperative histologic confirmation. The results after PPPD (postoperative morbidity and mortality, long-term survival) are similar to that following conventional Whipple procedure, if the principles of viable and tumor free margins are observed.


Subject(s)
Pancreatic Neoplasms/surgery , Pancreaticoduodenectomy/methods , Adult , Aged , Female , Humans , Length of Stay/statistics & numerical data , Male , Medical Records , Middle Aged , Pancreatic Neoplasms/mortality , Pancreatic Neoplasms/pathology , Retrospective Studies , Risk Factors , Romania , Survival Analysis , Treatment Outcome
17.
Chirurgia (Bucur) ; 102(6): 651-64, 2007.
Article in Romanian | MEDLINE | ID: mdl-18323227

ABSTRACT

OBJECTIVE: We performed a retrospective study to assess the postoperative results, long-term survival and quality of life after pylorus preserving pancreaticoduodenectomy (PPPD) versus standard Whipple pancreaticoduodenectomy (WPD). METHODS: A retrospective study was performed in a nonselected series of 137 patients who were operated in the Surgical Clinics of "St. Spiridon" University Hospital Iasi, Romania, from January 1st, 1995 till December 31, 2005. Demographics, preoperative and intraoperative data, as well as postoperative morbidity, mortality and follow-up were analyzed. Quality of life, after to at least six months after discharge, was also studied. RESULTS: There were no significant differences noted in demographics data. Jaundice was more frequent in the PPPD group as for WPD patients (p=0.047). For the most patients the digestive reconstruction after resection were performed as in Child technique: the first anastomosis was pancreaticojejunostomy (end-to-end or end-to-side), the second anastomosis was hepaticojejunostomy (end-to-side) and the last anastomosis was gastrojejunostomy end-to-side (duodenojejunostomy in PPPD group). For 31 cases a pancreatico-gastrostomy were performed. We also noted 14 cases with pancreatico-gastrostomy and duodenojejunostomy end-to-end, and a Roux jejunal loop for 3 patients with previous gastrectomy and gastrojejunostomy (Reichel-Polya). The operating time was shorter in the PPPD group as in WPD (p < 10-3), but the mean blood loss was the same. Postoperative morbidity rate was 46.8% in PPPD group vs 39.2% in WPD (p > 0.05), but the reintervention rate was significant higher in PPPD group (30.6% vs 15%; p = 0.027). We also noted no significant differences of Delayed Gastric Emptying, postoperative mortality rate (14.5% in PPPD group vs 10.1% in WPD group) and mean survival time (42.42 months (24.94 - 59.89; 95% CI) in PPPD group vs 46.78 months (28.07 - 61.50; 95% CI) in WPD group; log rank test p = 0.643). Pathological exam diagnosed a malignancy in 109 cases (54 cases with pancreatic cancer); we noted chronic pancreatitis in 22 cases. Quality of life was also the same in the two groups. CONCLUSIONS: PPPD and WPD were associated with comparable results, but, there is a tendency of increase rate of postoperative morbidity and mortality for PPPD patients. We also noted that postoperative quality of life is the same for both procedures.


Subject(s)
Pancreatic Neoplasms/surgery , Pancreaticoduodenectomy/methods , Pylorus/surgery , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pancreatic Neoplasms/mortality , Pancreatic Neoplasms/pathology , Pancreaticoduodenectomy/adverse effects , Pancreatitis/etiology , Quality of Life , Retrospective Studies , Risk Factors , Survival Analysis , Treatment Outcome
18.
Rev Med Chir Soc Med Nat Iasi ; 111(4): 925-31, 2007.
Article in Romanian | MEDLINE | ID: mdl-18389782

ABSTRACT

Stoma is a Greek word meaning mouth or opening. There are many types of surgical stomas and they may be raised on many areas of the abdominal wall. A stoma may be temporary or permanent, may be needed in any age group and may be sited on any part of the abdomen. The specific digestive pathology that could have as result of the surgical management a stoma is represented by colon, rectal and anal cancer, diverticular disease of the colon and rectum, Crohn's disease, ischaemic bowel, volvulus, trauma, Hirschprung disease, imperforate anus, fecal incontinence. This paper aim is to asses the management of fecal stomas and the necessity of a trained ostomy support team.


Subject(s)
Colorectal Neoplasms/surgery , Colostomy/education , Colostomy/methods , Humans , Ostomy/education , Ostomy/methods , Patient Education as Topic/methods
19.
Rev Med Chir Soc Med Nat Iasi ; 111(3): 673-7, 2007.
Article in Romanian | MEDLINE | ID: mdl-18293699

ABSTRACT

Malignant mesothelioma of the peritoneum is a rare neoplasm with a rapidly fatal course. The median survival range is from 5 to 12 months in untreated cases with little improvement seen in patients receiving multimodality therapy. Although most cases occur in the fifth and sixth decades, peritoneal mesothelioma can be seen in any age group. Approximately 30% of all mesotheliomas arise solely from the peritoneum. Asbestos exposure, primarily of the crocidolite variety, has been implicated in the pathogenesis of this malignancy, as was established in South Africa in the 1960s. Half of reported cases have a history of asbestos exposure. The diagnosis of peritoneal mesothelioma is often delayed, in part because of the usually long latent period (peaking at 40-45 years from the time of initial exposure to asbestos) and because the common presenting symptoms of weight loss, usually with a full abdomen, malaise, and abdominal discomfort, are mild and nonspecific. This paper aim is to present a case report regarding a patient diagnosed with malignant peritoneal mesothelioma with an unpredictable evolution.


Subject(s)
Mesothelioma/diagnosis , Mesothelioma/therapy , Neoplasm Recurrence, Local , Peritoneal Neoplasms/diagnosis , Peritoneal Neoplasms/therapy , Antineoplastic Agents/therapeutic use , Cisplatin/therapeutic use , Humans , Male , Mesothelioma/drug therapy , Mesothelioma/pathology , Mesothelioma/surgery , Peritoneal Neoplasms/drug therapy , Peritoneal Neoplasms/pathology , Peritoneal Neoplasms/surgery , Prognosis , Reoperation
20.
Chirurgia (Bucur) ; 101(2): 135-9, 2006.
Article in English | MEDLINE | ID: mdl-16752678

ABSTRACT

Acute severe pancreatitis represents a disease with multiple complications and a high mortality rate. The clinical evolution is related to the acute systemic inflammatory response syndrome, due mainly to inflammatory mediators and pancreatic enzymes and to the infectious complications representing a peak in the incidence of death. This study aims to retrospectively analyse the outcome of patients diagnosed with acute severe pancreatitis, conservatively treated versus those surgically managed. This study includes 151 patients, each having been diagnosed with acute severe pancreatitis (CT using Balthazar's) distributed in term of age, sex and severity parameters. The conservative treatment has included antibiotics, and anti-inflammatory drugs. The imaging and biological parameters were further statistically analysed. The clinical-biological evolution has been paralleled by the CT severity index. The conservatively treated group had a better clinical-biological outcome (p<0.05), when compared with the surgically treated group. Morbidity was significantly higher in the group exposed to surgical treatment. Conservative treatment should be the first option in acute severe pancreatitis management.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Pancreatitis, Acute Necrotizing/therapy , Adult , Drug Therapy, Combination , Female , Histamine H2 Antagonists/therapeutic use , Humans , Male , Middle Aged , Pancreatectomy , Pancreatitis, Acute Necrotizing/diagnosis , Pancreatitis, Acute Necrotizing/diet therapy , Pancreatitis, Acute Necrotizing/surgery , Retrospective Studies , Sensitivity and Specificity , Severity of Illness Index , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...